An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Bristol Myers Squibb to Participate in the 2024 Goldman Sachs Healthcare C-Suite Unscripted Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Bristol Myers Squibb (NYSE: BMY) to participate in 2024 Goldman Sachs Healthcare C-Suite Unscripted Conference
Positive
None.
Negative
None.
PRINCETON, N.J.--(BUSINESS WIRE)--
Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the 2024 Goldman Sachs Healthcare C-Suite Unscripted Conference in New York City on Thursday, January 4, 2024. Adam Lenkowsky, executive vice president, chief commercialization officer, will answer questions about the company during a fireside chat at 11 a.m. ET.
Investors and the general public are invited to listen to a live webcast of the session here. An archived edition of the session will be available following its conclusion.
About Bristol Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
What is the latest announcement from Bristol Myers Squibb (NYSE: BMY)?
Bristol Myers Squibb (NYSE: BMY) will participate in the 2024 Goldman Sachs Healthcare C-Suite Unscripted Conference in New York City on Thursday, January 4, 2024.
Who will be representing Bristol Myers Squibb (NYSE: BMY) at the conference?
Adam Lenkowsky, executive vice president, chief commercialization officer, will be answering questions on behalf of Bristol Myers Squibb (NYSE: BMY) at the conference.
When and where will the conference take place?
The 2024 Goldman Sachs Healthcare C-Suite Unscripted Conference will be held in New York City on Thursday, January 4, 2024.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
